Taiwan · Delayed Price · Currency is TWD Uwell Biopharma Statistics
Total Valuation
Uwell Biopharma has a market cap or net worth of TWD 6.83 billion. The enterprise value is 6.56 billion.
| Market Cap | 6.83B |
| Enterprise Value | 6.56B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Uwell Biopharma has 200.00 million shares outstanding. The number of shares has increased by 30.97% in one year.
| Current Share Class | 200.00M |
| Shares Outstanding | 200.00M |
| Shares Change (YoY) | +30.97% |
| Shares Change (QoQ) | +61.94% |
| Owned by Insiders (%) | 22.87% |
| Owned by Institutions (%) | 9.83% |
| Float | 78.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 195,142.86 |
| PB Ratio | 22.41 |
| P/TBV Ratio | 22.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.26, with a Debt / Equity ratio of 0.04.
| Current Ratio | 14.26 |
| Quick Ratio | 14.15 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.19 |
| Interest Coverage | -380.68 |
Financial Efficiency
Return on equity (ROE) is -26.77% and return on invested capital (ROIC) is -17.24%.
| Return on Equity (ROE) | -26.77% |
| Return on Assets (ROA) | -16.40% |
| Return on Invested Capital (ROIC) | -17.24% |
| Return on Capital Employed (ROCE) | -24.32% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 34.24 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 48.89 |
| Average Volume (20 Days) | 103,494 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Uwell Biopharma had revenue of TWD 35,000 and -71.61 million in losses. Loss per share was -0.37.
| Revenue | 35,000 |
| Gross Profit | 28,000 |
| Operating Income | -75.76M |
| Pretax Income | -71.61M |
| Net Income | -71.61M |
| EBITDA | -72.20M |
| EBIT | -75.76M |
| Loss Per Share | -0.37 |
Balance Sheet
The company has 285.27 million in cash and 11.89 million in debt, with a net cash position of 273.37 million or 1.37 per share.
| Cash & Cash Equivalents | 285.27M |
| Total Debt | 11.89M |
| Net Cash | 273.37M |
| Net Cash Per Share | 1.37 |
| Equity (Book Value) | 304.80M |
| Book Value Per Share | 1.51 |
| Working Capital | 267.87M |
Cash Flow
In the last 12 months, operating cash flow was -58.62 million and capital expenditures -5.53 million, giving a free cash flow of -64.16 million.
| Operating Cash Flow | -58.62M |
| Capital Expenditures | -5.53M |
| Depreciation & Amortization | 3.24M |
| Net Borrowing | -5.33M |
| Free Cash Flow | -64.16M |
| FCF Per Share | -0.32 |
Margins
| Gross Margin | 80.00% |
| Operating Margin | -216,445.71% |
| Pretax Margin | -204,605.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Uwell Biopharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.97% |
| Shareholder Yield | -30.97% |
| Earnings Yield | -1.05% |
| FCF Yield | -0.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |